108 related articles for article (PubMed ID: 3756793)
41. Prostate-specific antigen value as a marker in breast cancer.
Narita D; Cimpean AM; Anghel A; Raica M
Neoplasma; 2006; 53(2):161-7. PubMed ID: 16575473
[TBL] [Abstract][Full Text] [Related]
42. [Estrogen receptor kinetics in benign and malignant diseases of the breast and their clinical implication].
Ebuchi M
Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):746-54. PubMed ID: 3627097
[TBL] [Abstract][Full Text] [Related]
43. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
Reiner GC; Katzenellenbogen BS
Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
[TBL] [Abstract][Full Text] [Related]
44. [Cytosol estrogen and progesterone receptors in female genital system malignant tumors].
Han SW; He B; Tang QP
Zhonghua Fu Chan Ke Za Zhi; 1994 Jan; 29(1):12-5, 59. PubMed ID: 8033616
[TBL] [Abstract][Full Text] [Related]
45. The prognostic importance of steroid receptors in endometrial carcinoma.
Palmer DC; Muir IM; Alexander AI; Cauchi M; Bennett RC; Quinn MA
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):388-93. PubMed ID: 3405554
[TBL] [Abstract][Full Text] [Related]
46. [Determination of estrogen and progesterone receptors in epithelioma of the uterine cervix. (Apropos of a series of 101 cases)].
Fenton J; Asselain B; Magdelenat H
Bull Cancer; 1986; 73(2):124-6. PubMed ID: 3730632
[No Abstract] [Full Text] [Related]
47. Estrogen and progesterone receptors and tamoxifen in malignant melanoma.
Karakousis CP; Lopez RE; Bhakoo HS; Rosen F; Moore R; Carlson M
Cancer Treat Rep; 1980; 64(6-7):819-27. PubMed ID: 7427967
[TBL] [Abstract][Full Text] [Related]
48. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma.
Creasman WT; Soper JT; McCarty KS; McCarty KS; Hinshaw W; Clarke-Pearson DL
Am J Obstet Gynecol; 1985 Apr; 151(7):922-32. PubMed ID: 3985057
[TBL] [Abstract][Full Text] [Related]
49. Interaction of ovarian hormones with normal endometrium and endometrial adenocarcinoma.
Gurpide E; Holinka CF; Fleming H; Fridman O; Deligdisch L; Deppe G
Mt Sinai J Med; 1980; 47(4):394-7. PubMed ID: 6968031
[TBL] [Abstract][Full Text] [Related]
50. Localization of an estrogen-responsive protein in the human cervix during menstrual cycle, pregnancy, and menopause and in abnormal cervical epithelia without atypia.
Ciocca DR; Puy LA; Lo Castro G
Am J Obstet Gynecol; 1986 Nov; 155(5):1090-6. PubMed ID: 3535518
[TBL] [Abstract][Full Text] [Related]
51. Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis.
Molino A; Turazza M; Bonetti A; Biondani P; Griso C; Adami L; Corgnati A; Nortilli R; Pollini GP; Modena S
Oncology; 1992; 49(2):82-8. PubMed ID: 1574256
[TBL] [Abstract][Full Text] [Related]
52. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
Ehrlich CE; Young PC; Stehman FB; Sutton GP; Alford WM
Am J Obstet Gynecol; 1988 Apr; 158(4):796-807. PubMed ID: 2966586
[TBL] [Abstract][Full Text] [Related]
53. Variation of cytoplasmic content of estrogen and progesterone receptors in the mammary gland and uterus of rats at time of parturition.
Yu WC; Leung BS
Biol Reprod; 1982 Oct; 27(3):658-64. PubMed ID: 7139013
[TBL] [Abstract][Full Text] [Related]
54. [Relation between the levels of estrogen receptor and progesterone receptor and clinicopathological status in human endometrial carcinomas].
Yi X; Yao X
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Mar; 22(1):66-9. PubMed ID: 1774041
[TBL] [Abstract][Full Text] [Related]
55. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors.
Thorpe SM
Cancer Res; 1987 Apr; 47(7):1830-5. PubMed ID: 3545455
[TBL] [Abstract][Full Text] [Related]
56. Variations in steroid hormone receptor content throughout age and menopausal periods, and menstrual cycle in breast cancer patients.
Nikolić-Vukosavljević D; Vasiljević N; Branković-Magić M; Polić D
Neoplasma; 1996; 43(3):163-9. PubMed ID: 8841503
[TBL] [Abstract][Full Text] [Related]
57. The prognostic and therapeutic value of steroid hormone receptors in breast cancer.
Elias EG
Md Med J; 1986 Nov; 35(11):949. PubMed ID: 3807670
[No Abstract] [Full Text] [Related]
58. Regulation of estrogen/progestogen receptors in the endometrium.
Casper RF
Int J Fertil Menopausal Stud; 1996; 41(1):16-21. PubMed ID: 8673152
[TBL] [Abstract][Full Text] [Related]
59. [Estrogen and progesterone receptors in corpus uteri carcinoma and their clinical significance].
Kleine W; Fuchs A; deGregorio G; Geyer H
Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):884-7. PubMed ID: 6925560
[TBL] [Abstract][Full Text] [Related]
60. [Endometrial cancer and steroid hormone receptors].
Nyholm HC
Ugeskr Laeger; 1990 Feb; 152(9):593-7. PubMed ID: 2408223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
